Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer

NCT07662031 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Metastatic Colorectal Cancer

Interventions

BIOLOGICAL: Tovecimig
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: 5-Fluorouracil (5-FU)

Sponsor

Washington University School of Medicine

Collaborators

[object Object]